Pathophysiology and Management of Thrombocytopenia in Bone Marrow Failure: Possible Clinical Applications of TPO Receptor Agonists in Aplastic Anemia and Myelodysplastic Syndromes

International Journal of Hematology - Japan
doi 10.1007/s12185-013-1352-6
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Late Mortality After Allogeneic BMT in Childhood for Bone Marrow Failure Syndromes and Severe Aplastic Anemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Myelodysplastic (Preleukemia) Syndromes: The Bone Marrow Factory Failure Problem

Mayo Clinic Proceedings
Medicine
1995English

Quantification of Marrow CD34+ Cells: An Important Tool for Distinguishing Between Hypoplastic Myelodysplastic Syndromes and Aplastic Anemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2011English

Inherited Bone Marrow Failure Syndromes in Adolescents and Young Adults

Annals of Medicine
Medicine
2014English

Telomere Length in Inherited Bone Marrow Failure Syndromes

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Aplastic Anemia: Presence in Human Bone Marrow of Cells That Suppress Myelopoiesis.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1976English

Recent Advances in the Pathophysiology and Clinical Management of Anemia

Internal Medicine
Internal MedicineMedicine
2005English

Association of Severe Thrombocytopenia and Poor Prognosis in Pregnancies With Aplastic Anemia

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy